Organizational effects of oxytocin on serotonin innervation

Developmental Psychobiology

Volumn 54, Issue 1, 2012, Pages 92-97

  Eaton, Jennifer L ^a,b   Roache, Laura ^a   Nguyen, Khanhbao N ^a   Cushing, Bruce S ^a   Troyer, Emma ^a   Papademetriou, Eros ^c   Raghanti, Mary Ann ^d  

^a UNIVERSITY OF AKRON   (United States)

^b SUMMA HEALTH SYSTEM   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d KENT STATE UNIVERSITY   (United States)

Author keywords

Aggression; Prairie vole; Stereology

Indexed keywords

OXYTOCIN; SEROTONIN;

ANIMAL; ARTICLE; ARVICOLINAE; BRAIN; DRUG ANTAGONISM; DRUG EFFECT; MALE; METABOLISM; NERVE CELL;

ANIMALS; ARVICOLINAE; BRAIN; MALE; NEURONS; OXYTOCIN; SEROTONIN;

MICROTUS OCHROGASTER; MURIDAE;

EID: 80555136242     PISSN: 00121630     EISSN: 10982302     Source Type: Journal    
DOI: 10.1002/dev.20566     Document Type: Article

References (40)

1. Alstein, M., & Gainer, H. (1988). Differential biosynthesis and posttranslational processing of vasopressin and oxytocin in rat brain during embryonic and postnatal development. Journal of Neuroscience, 8, 3967-3977.
2. Azmitia, E. C., Singh, J. S., & Whitaker-Azmitia, P. M. (2011). Increased serotonin axons (immunoreatcive to 5HT transporter) in postmortem brains from young autism donors. Neuropharmacology, 60, 1347-1354.
3. Bales, K. L., Plotsky, P. M., Young, L. J., Lim, M. M., Grotte, N., Ferrer, E., et al. (2007). Neonatal oxytocin manipulations have long-lasting, sexually dimorphic effects on vasopressin receptors. Neuroscience, 144, 38-45.
4. Calhoun, M. E., & Mouton, P. R. (2000). Length measurement: New developments in neurostereology and 3D imagery. Journal of Chemical Neuroanatomy, 21, 257-265.
5. Calhoun, M. E., Mao, Y., Roberts, J. A., & Rapp, P. R. (2004). Reduction in hippocampal cholinergic innervation is unrelated to recognition memory impairment in aged rhesus monkeys. Journal of Comparative Neurology, 475, 238-246.
6. Carter, C. S. (2003). Developmental consequences of oxytocin. Physiology and Behavior, 79, 383-397.
7. Carter, C. S. (2007). Sex differences in oxytocin and vasopressin: Implications for autism spectrum disorders? Behavior and Brain Research, 176, 170-186.
8. Cools, R., Roberts, A. C., & Robbins, T. W. (2008). Serotoninergic regulation of emotional and behavioural control processes. Trends in Cognitive Science, 12, 31-40.
9. Choy, V. J., & Watkins, W. B. (1979). Maturation of the hypothalamo-neurohypophysial system. Cell and Tissue Research, 197, 325-336.
10. Cushing, B. S., & Kramer, K. M. (2005). Mechanisms underlying epigenetic effects of early social experience: The role of neuropeptides and steroids. Neuroscience and Biobehavioral Reviews, 29, 1089-1115.
11. Cushing, B. S., Yamamoto, Y., Hoffman, G. E., & Carter, C. S. (2003). Central expression of c-Fos in neonatal male and female prairie voles in response to treatment with oxytocin. Developmental Brain Research, 143, 129-136.
12. Johnson, A. E., Coirini, H., Ball, G. F., & McEwen, B. S. (1989). Anatomical localization of the effects of 17-beta-estradiol on oxytocin receptor-binding in the ventromedial hypothalamic nucleus. Endocrinology, 124, 207-211.
13. Jorgensen, H., Riis, M., Knigge, U., Kjaer, A., & Warberg, J. (2003). Serotonin receptors involved in vasopressin and oxytocin secretion. Journal of Neuroendocrinology, 15, 242-249.
14. Kramer, K. M., Cushing, B. S., & Carter, C. S. (2003). Developmental effects of oxytocin on stress response: Single versus repeated exposure. Physiology and Behavior, 79, 775-782.
15. Kramer, K. M., Yoshida, S., Papademetriou, E., & Cushing, B. S. (2007). The organizational effects of oxytocin on the central expression of estrogen receptor alpha and oxytocin in adulthood. BioMed Central Neuroscience, 8, 71.
16. Kreczmanski, P., Schmidt-Kastner, R., Heinsen, H., Steinbusch, H. W., Hof, P. R., & Schmitz, C. (2005). Stereological studies of capillary length density in the frontal cortex of schizophrenics. Acta Neuropathology, 109, 510-558.
17. Levy, A. D., & Van de Kar, L. D. (1992). Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants. Life Sciences, 51, 82-94.
18. Li, Q., Levy, A. D., Cabrera, T. M., Brownfield, M. S., Battaglia, G., & Van de Kar, L. D. (1993). Long-term flouxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Research, 630, 148-156.
19. Marazziti, D., & Dell'Osso, M. C. (2008). The role of oxytocin in neuropsychiatric disorders. Current Medical Chemistry, 7, 698-704.
20. McCarthy, M. M., McDonald, C. H., Brooks, P. J., & Goldman, D. (1996). An anxiolytic action of oxytocin is enhanced by estrogen in the mouse. Physiology and Behavior, 60, 1209-1215.
21. Mouton, P. R., Gokhale, A. M., Ward, N. L., & West, M. J. (2002). Stereological length estimation using spherical probes. Journal of Microscopy, 206, 54-64.
22. Pournajafi-Nazarloo, H., Carr, M. S., Papademetriou, E., Schmidt, J. V., & Cushing, B. S. (2007). Oxytocin selectively increases ERα mRNA in the neonatal hypothalamus and hippocampus of female prairie voles. Neuropeptides, 41, 39-44.
23. Nelson, R. J., & Trainor, B. C. (2007). Neural mechanisms of aggression. Nature Reviews Neuroscience, 8, 536-546.
24. Neumann, I. D. (2008). Brain oxytocin: A key regulator of emotional and social behaviours in both females and males. Journal of Neuroendocrinology, 20, 858-865.
25. Osei-Owusu, P., James, A., Crane, J., & Scrogin, K. E. (2005). 5-Hydroxytryptamine 1A receptors in the paraventricular nucleus of the hypothalamus mediate oxytocin and adrenocorticotropin hormone release and some behavioral components of the serotonin syndrome. Journal of Pharmacology and Experimental Therapy, 313, 1324-1330.
26. Perry, A. N., Paramodilok, A., & Cushing, B. S. (2009). Neonatal oxytocin alters subsequent estrogen receptor alpha protein expression and estrogen sensitivity in the female rat. Behavior and Brain Research, 205, 154-161.
27. Raghanti, M. A., Stimpson, C. D., Marcinkiewicz, J. L., Erwin, J. M., Hof, P. R., & Sherwood, C. C. (2008a). Cortical dopaminergic innervation among humans, chimpanzees, and macaque monkeys: A comparative study. Neuroscience, 155, 203-220.
28. Raghanti, M. A., Stimpson, C. D., Marcinkiewicz, J. L., Erwin, J. M., Hof, P. R., & Sherwood, C. C. (2008b). Cholinergic innervation of the frontal cortex: Differences among humans, chimpanzees, and macaques. Journal of Comparative Neurology, 506, 409-424.
29. Raghanti, M. A., Stimpson, C. D., Marcinkiewicz, J. L., Erwin, J. M., Hof, P. R., & Sherwood, C. C. (2008c). Differences in cortical serotonergic innervation among humans, chimpanzees, and macaque monkeys: A comparative study. Cerebral Cortex, 18, 584-597.
30. Ross, H. E., & Young, L. J. (2009). Oxytocin and the neural mechanisms regulating social cognition and affiliative behavior. Frontiers in Neuroendocrinology, 30, 534-547.
31. Shapiro, L. E., & Insel, T. R. (1989). Ontogeny of oxytocin receptors in rat forebrain-A quantitative study. Synapse, 4, 259-266.
32. Uvnäs-Moberg, K., Björkstrand, E., Hillegaart, V., & Ahlenius, S. (1999). Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berlin), 142, 95-101.
33. Uvnäs-Moberg, K., Hillegaart, V., Alster, P., & Ahlenius, S. (1996). Effects of 5-HT agonists, selective for different receptor subtypes, on oxytocin, CCK, gastrin and somatostatin plasma levels in the rat. Neuropharmacology, 35, 1635-1640.
34. Van de Kar, L. D., Rittenhouse, P. A., Li, Q., Levy, A. D., & Brownfield, M. S. (1995). Hypothalamic paraventricular, but not supraoptic neurons, mediate the serotonergic stimulation of oxytocin secretion. Brain Research Bulletin, 36, 45-50.
35. Wang, Z. X., Young, L. J., Liu, Y., & Insel, T. R. (1997). Species Differences in vasopressin receptor binding are evident early in development: Comparative anatomic studies in prairie and montane voles. Journal of Comparative Neurology, 378, 535-546.
36. Watson, R. E., Wiegand, S. J., Clough, R. W., & Hoffman, G. E. (1986). Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides, 7, 155-159.
37. Yamamoto, Y., Carter, C. S., & Cushing, B. S. (2006). Neonatal manipulation of oxytocin affects expression of estrogen receptor alpha. Neuroscience, 137, 157-164.
38. Yamamoto, Y., Cushing, B. S., Kramer, K. M., Epperson, P. D., Hoffman, G. E., & Carter, C. S. (2004). Neonatal manipulations of oxytocin alter expression of oxytocin and vasopressin immunoreactive cells in the paraventricular nucleus of the hypothalamus in a gender-specific manner. Neuroscience, 125, 947-955.
39. Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L. J., Onaka, T., et al. (2009). Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. Journal of Neuroscience, 29, 2259-2271.
40. Yoshimura, R., Kimura, T., Watanabe, D., & Kiyama, H. (1996). Differential expression of oxytocin receptor mRNA in the developing rat brain. Neuroscience Research, 24, 291-304.